Related references
Note: Only part of the references are listed.68Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism
Marti Boss et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
CPPs to the Test: Effects on Binding, Uptake and Biodistribution of a Tumor Targeting Nanobody
Estel Collado Camps et al.
PHARMACEUTICALS (2021)
Targeted Optical Imaging of the Glucagonlike Peptide 1 Receptor Using Exendin-4-IRDye 800CW
Marti Boss et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
SuperPlots: Communicating reproducibility and variability in cell biology
Samuel J. Lord et al.
JOURNAL OF CELL BIOLOGY (2020)
Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor-Positive Lesions
Marti Boss et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Improving antibody-based therapies by chemical engineering of antibodies with multimeric cell-penetrating peptides for elevated intracellular delivery
Max Sauter et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same?
Raffaella Gentilella et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2019)
Exendin-4 analogs in insulinoma theranostics
Tom J. P. Jansen et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2019)
Measuring the Pancreatic β Cell Mass in Vivo with Exendin SPECT during Hyperglycemia and Severe Insulitis
Lieke Joosten et al.
MOLECULAR PHARMACEUTICS (2019)
Impact Of Penetratin Stereochemistry On The Oral Bioavailability Of Insulin-Loaded Solid Lipid Nanoparticles
Bader B. Alsulays et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
alpha-Helix or beta-Turn? An Investigation into N-Terminally Constrained Analogues of Glucagon-like Peptide 1 (GLP-1) and Exendin-4
Alberto Oddo et al.
BIOCHEMISTRY (2018)
Penetration in 3D tumor spheroids and explants: Adding a further dimension to the structure-activity relationship of cell-penetrating peptides
Dirk van den Brand et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2018)
Bombesin/oligoarginine fusion peptides for gastrin releasing peptide receptor (GRPR) targeted gene delivery
Anjuman Ara Begum et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
An opportunistic route to success: Towards a change of paradigm to fully exploit the potential of cell-penetrating peptides
Estel Collado Camps et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Acid-Induced Activated Cell-Penetrating Peptide-Modified Cholesterol-Conjugated Polyoxyethylene Sorbitol Oleate Mixed Micelles for pH-Triggered Drug Release and Efficient Brain Tumor Targeting Based on a Charge Reversal Mechanism
Yu Tian et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Inhibition of Inflammatory Changes in Human Myometrial Cells by Cell Penetrating Peptide and Small Molecule Inhibitors of NFκB
Leo R. I. Gurney et al.
FRONTIERS IN IMMUNOLOGY (2018)
Exenatide: pharmacokinetics, clinical use, and future directions
Filip K. Knop et al.
EXPERT OPINION ON PHARMACOTHERAPY (2017)
A Conjugate of an Anti-Epidermal Growth Factor Receptor (EGFR) VHH and a Cell-Penetrating Peptide Drives Receptor Internalization and Blocks EGFR Activation
Sanne A. M. van Lith et al.
CHEMBIOCHEM (2017)
Cell-Permeable, MMP-2 Activatable, Nickel Ferrite and His-Tagged Fusion Protein Self-Assembled Fluorescent Nanoprobe for Tumor Magnetic-Targeting and Imaging
Lu Sun et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Development of 111In-labeled exendin(9-39) derivatives for single-photon emission computed tomography imaging of insulinoma
Hiroyuki Kimura et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Facile Noninvasive Retinal Gene Delivery Enabled by Penetratin
Chang Liu et al.
ACS APPLIED MATERIALS & INTERFACES (2016)
Approaches to Improve the Pharmacokinetics of Radiolabeled Glucagon-Like Peptide-1 Receptor Ligands Using Antagonistic Tracers
Svetlana N. Rylova et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Strain Differences Determine the Suitability of Animal Models for Noninvasive In Vivo Beta Cell Mass Determination with Radiolabeled Exendin
Stefanie M. A. Willekens et al.
MOLECULAR IMAGING AND BIOLOGY (2016)
Conjugation of Cell-Penetrating Peptides to Parathyroid Hormone Affects Its Structure, Potency, and Transepithelial Permeation
Mie Kristensen et al.
BIOCONJUGATE CHEMISTRY (2015)
PET imaging of DNA damage using 89Zr-labelled anti-γH2AX-TAT immunoconjugates
James C. Knight et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Acid-Active Cell-Penetrating Peptides for in Vivo Tumor-Targeted Drug Delivery
Erlei Jin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study
Emanuel Christ et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Radiolabelled GLP-1 analogues for in vivo targeting of insulinomas
Maarten Brom et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2012)
Cell-penetrating peptides: classes, origin, and current landscape
Francesca Milletti
DRUG DISCOVERY TODAY (2012)
Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo
Ikuhiko Nakase et al.
JOURNAL OF CONTROLLED RELEASE (2012)
The Pharmacokinetics of Cell-Penetrating Peptides
Dikran Sarko et al.
MOLECULAR PHARMACEUTICS (2010)
GLP-1 receptor antagonist as a potential probe for pancreatic β-cell imaging
Eri Mukai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes -: Many differences, few similarities
M Cnop et al.
DIABETES (2005)
Share Paper
